Vertex Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Vertex Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Vertex Pharmaceuticals Inc Strategy Report
- Understand Vertex Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on Vertex Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
28 Sep 2022 | Vertex Pharmaceuticals Enters into Licensing Agreement with MaxCyte | Licensing Agreement |
Vertex Pharmaceuticals Inc
|
MaxCyte Inc
|
20 Jul 2022 | Vertex Pharma Enters into Co-Development Agreement with Verve Therapeutics | Partnership | - |
Verve Therapeutics Inc
Vertex Pharmaceuticals Inc |
09 Jul 2022 | Vertex Pharma to Acquire ViaCyte | Acquisition |
Vertex Pharmaceuticals Inc
|
ViaCyte, Inc.
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer